Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
BMC Infect Dis ; 24(1): 491, 2024 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-38745172

RESUMEN

Brucellosis, a zoonotic disease caused by Brucella species, poses a significant global health concern. Among its diverse clinical manifestations, neurobrucellosis remains an infrequent yet debilitating complication. Here, we present a rare case of neurobrucellosis with unusual presentations in a 45-year-old woman. The patient's clinical course included progressive lower extremity weakness, muscle wasting, and double vision, prompting a comprehensive diagnostic evaluation. Notable findings included polyneuropathy, elevated brucella agglutination titers in both cerebrospinal fluid and blood, abnormal EMG-NCV tests, and resolving symptoms with antibiotic therapy. The clinical presentation, diagnostic challenges, and differentiation from other neurological conditions are discussed. This case underscores the importance of considering neurobrucellosis in regions where brucellosis is prevalent and highlights this rare neurological complication's distinctive clinical and radiological features. Early recognition and appropriate treatment are crucial to mitigate the significant morbidity associated with neurobrucellosis.


Asunto(s)
Brucelosis , Polirradiculoneuropatía , Humanos , Femenino , Brucelosis/diagnóstico , Brucelosis/complicaciones , Brucelosis/tratamiento farmacológico , Persona de Mediana Edad , Polirradiculoneuropatía/diagnóstico , Polirradiculoneuropatía/microbiología , Antibacterianos/uso terapéutico , Brucella/aislamiento & purificación
2.
J Burn Care Res ; 45(1): 200-204, 2024 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-37935438

RESUMEN

The aim of this study was to evaluate the effectiveness of 0.08% diluted lidocaine solution during and after wound dressing procedures for patients with burn injuries. Fifty burn patients aged 18-60 years, with burns ranging from 30% to 60%, were divided into intervention and control groups. The intervention group received dressings diluted with 0.08% lidocaine solution, while the control group received a placebo. Vital signs were continuously monitored before, during, and after the application of new dressings. Pain was assessed using the Visual Analog Scale (VAS) checklist before and after the dressing change in both groups. The study included 25 participants in the intervention group with a mean age of 40.2 ± 6.5 and 25 participants in the control group with a mean age of 39.1 ± 6.8. The groups were comparable in terms of baseline characteristics, including gender, age, weight, height, body mass index, percentage and degree of burns, as well as average morphine intake. No significant differences were observed in vital signs or pain scores before and after dressing changes between the 2 groups. However, the intervention group reported significantly lower pain scores during the dressing change compared to the control group (P < .001). Diluted lidocaine solution during wound dressing procedures can reduce pain in burn patients. Further research with larger sample sizes is needed to establish the safety and efficacy of this technique. This study suggests that lidocaine can be a useful tool in the management of pain during dressing changes for burn patients.


Asunto(s)
Quemaduras , Lidocaína , Adulto , Humanos , Persona de Mediana Edad , Vendajes , Quemaduras/complicaciones , Quemaduras/terapia , Lidocaína/uso terapéutico , Dolor/tratamiento farmacológico , Dolor/etiología , Dolor/prevención & control , Percepción del Dolor , Adolescente , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...